Literature DB >> 7278494

Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type.

M N Rossor, J F Rehfeld, P C Emson, C Q Mountjoy, M Roth, L L Iversen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7278494     DOI： 10.1016/0024-3205(81)90334-9

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  5 in total

1.  Cholecystokinin peptides and receptor binding in Alzheimer's disease.

Authors:  C Löfberg; J Harro; C G Gottfries; L Oreland
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 2.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

3.  Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis.

Authors:  P Tirassa; L Aloe; C Stenfors; P Turrini; T Lundeberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.

Authors:  K Fujiyoshi; H Suga; K Okamoto; S Nakamura; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

5.  Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.

Authors:  M N Rossor
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.